Expression of survivin is correlated with cancer cell apoptosis and is involved in the development of human pancreatic duct cell tumors

Cancer

Volumn 92, Issue 2, 2001, Pages 271-278

  Satoh, Kennichi ^a   Kaneko, Kenzo ^a   Hirota, Morihisa ^a   Masamune, Atsushi ^a   Satoh, Akihiko ^a   Shimosegawa, Tooru ^a  

^a TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Apoptosis; Intraductal papillary mucinous tumor; Pancreatic carcinoma; Survivin

Indexed keywords

SURVIVIN;

ADENOMA; APOPTOSIS; ARTICLE; CANCER INVASION; CARCINOGENESIS; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MUCINOUS CARCINOMA; PANCREAS DUCT; PANCREAS TUMOR; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOCARCINOMA; APOPTOSIS; CARCINOMA, MEDULLARY; CARCINOMA, PANCREATIC DUCTAL; CARCINOMA, PAPILLARY; CELL TRANSFORMATION, NEOPLASTIC; CHRONIC DISEASE; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; MICROTUBULE-ASSOCIATED PROTEINS; NEOPLASM PROTEINS; PANCREAS; PANCREATIC NEOPLASMS; PANCREATITIS; PROTEIN BIOSYNTHESIS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; TUMOR CELLS, CULTURED; UP-REGULATION;

EID: 0035878930     PISSN: 0008543X     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0142(20010715)92:2<271::AID-CNCR1319>3.0.CO;2-0     Document Type: Article

References (21)

1. Intraductal papillary-mucinous tumors of the pancreas: Clinicopathologic features, outcome, and nomenclature
2. K-ras mutation and p53 protein accumulation in intraductal mucin-hypersecreting neoplasms of the pancreas
3. An immunohistochemical study of the c-erb B-2 oncogene product in intraductal mucin-hypersecreting neoplasms and in ductal cell carcinomas of the pancreas
4. Loss of chromosome 18q is an early event in pancreatic ductal tumorigenesis
5. Intraductal papillary-mucionus tumors of the pancreas: Imaging studies and treatment strategies
6. Surgery for mucin-producing pancreatic tumor
7. Apoptosis in the pathogenesis and treatment of disease
8. A novel anti-apoptosis gene, survivin, expressed in cancer and lymphoma
9. Anti-apoptosis gene, survivin, and prognosis of neuroblastoma
10. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer
11. Expression of a novel anti-apoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas
12. Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line
13. Pathology of nonendocrine pancreatic tumors
14. Oxidative stress induces NFkB DNA binding and inducible NOS mRNA in human epithelial cells
15. Fas ligand is frequently expressed in human pancreatic duct cell carcinoma
16. Human adenocarcinomas express Fas and Fas ligand yet are resistant to Fas-mediated apoptosis
17. IAP-family protein survivin inhibits caspase activity and apoptosis induced by Fas (CD95), Bax, caspases, and anticancer drugs
18. A novel anti-apoptosis gene: Re-expression of survivin messenger RNA as a prognosis marker in non-small-cell lung cancers
19. Infrequent stromal expression of gelatinase A and intact basement membrane in intraductal neoplasms of the pancreas
20. Survivin apoptosis: An interloper between cell death and cell proliferation in cancer